PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
297.09%
Net income growth above 1.5x MCHP's 24.60%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
2.23%
Less D&A growth vs. MCHP's 18.33%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
-119.50%
Negative yoy deferred tax while MCHP stands at 70.70%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
55.56%
SBC growth well above MCHP's 1.55%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-141.72%
Both reduce yoy usage, with MCHP at -135.64%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-158.86%
Both yoy AR lines negative, with MCHP at -1442.10%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-97.96%
Both reduce yoy inventory, with MCHP at -426.11%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-172.86%
Negative yoy AP while MCHP is 486.84%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-118.17%
Both reduce yoy usage, with MCHP at -76.81%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-282.14%
Both negative yoy, with MCHP at -43.61%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-42.35%
Negative yoy CFO while MCHP is 6.95%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
18.18%
CapEx growth well above MCHP's 3.67%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-100.00%
Both yoy lines negative, with MCHP at -100.00%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
31.31%
Some yoy expansion while MCHP is negative at -4.79%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
84.18%
Below 50% of MCHP's 3247.53%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
98.32%
Growth well above MCHP's 41.35%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
129.62%
Investing outflow well above MCHP's 19.74%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
100.00%
Debt repayment similar to MCHP's 99.96%. Walter Schloss sees parallel liability management or similar free cash flow availability.
9.88%
We slightly raise equity while MCHP is negative at -66.40%. John Neff sees competitor possibly preserving share count or buying back shares.
-23.65%
We cut yoy buybacks while MCHP is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.